Hyperglycemia-induced ubiquitination and degradation of β-catenin with the loss of platelet endothelial cell adhesion molecule-1 in retinal endothelial cells.
Animals
Diabetes Mellitus, Experimental
/ metabolism
Diabetes Mellitus, Type 1
/ metabolism
Endothelial Cells
/ metabolism
Hyperglycemia
/ metabolism
Male
Platelet Endothelial Cell Adhesion Molecule-1
/ metabolism
Proteolysis
Rats
Rats, Wistar
Retina
/ metabolism
Ubiquitination
beta Catenin
/ metabolism
PECAM-1
blood-retinal barrier
diabetic retinopathy
permeability
β-catenin
Journal
Microcirculation (New York, N.Y. : 1994)
ISSN: 1549-8719
Titre abrégé: Microcirculation
Pays: United States
ID NLM: 9434935
Informations de publication
Date de publication:
02 2020
02 2020
Historique:
received:
15
04
2019
revised:
13
09
2019
accepted:
16
10
2019
pubmed:
20
10
2019
medline:
10
4
2021
entrez:
20
10
2019
Statut:
ppublish
Résumé
Increased retinal vascular permeability is one of the earliest manifestations of diabetic retinopathy. The aim of this study was to investigate the role of hyperglycemia-induced platelet endothelial cell adhesion molecule-1 loss on retinal vascular permeability via the β-catenin pathway. Type I diabetes was induced in male Wistar rats using streptozotocin injections, with age-matched non-diabetic rats as controls. Rat retinal microvascular endothelial cells were grown under normal or high glucose conditions for 6 days. Small interfering Ribonucleic Acid was used to knock down platelet endothelial cell adhesion molecule-1 in rat retinal microvascular endothelial cells for loss-of-function studies. Retinas and rat retinal microvascular endothelial cells were subjected to Western blot, immunofluorescence labeling, and co-immunoprecipitation analyses to assess protein levels and interactions. A biotinylated gelatin and fluorescein isothiocyanate-avidin assay was used for retinal endothelial cell permeability studies. β-catenin, β-catenin/platelet endothelial cell adhesion molecule-1 interaction, active Src homology 2 domain-containing protein tyrosine phosphatase were significantly decreased, while β-catenin ubiquitination levels and endothelial permeability were significantly increased, in hyperglycemic retinal endothelial cells. Similar results were observed with platelet endothelial cell adhesion molecule-1 partial knockdown, where β-catenin and active Src homology 2 domain-containing protein tyrosine phosphatase levels were decreased, while phospho-β-catenin and retinal endothelial cell permeability were increased. Platelet endothelial cell adhesion molecule-1 loss may contribute to increased retinal endothelial cell permeability by attenuating β-catenin levels under hyperglycemic conditions.
Identifiants
pubmed: 31628816
doi: 10.1111/micc.12596
pmc: PMC7032995
mid: NIHMS1055734
doi:
Substances chimiques
Ctnnb1 protein, rat
0
Platelet Endothelial Cell Adhesion Molecule-1
0
beta Catenin
0
Types de publication
Journal Article
Research Support, N.I.H., Extramural
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
e12596Subventions
Organisme : NEI NIH HHS
ID : R01 EY025632
Pays : United States
Informations de copyright
© 2019 John Wiley & Sons Ltd.
Références
Nat Rev Mol Cell Biol. 2004 Apr;5(4):261-70
pubmed: 15071551
J Cell Biol. 1991 Sep;114(5):1059-68
pubmed: 1874786
EMBO J. 1997 Jul 1;16(13):3797-804
pubmed: 9233789
Blood. 2003 Jul 1;102(1):169-79
pubmed: 12649141
J Clin Invest. 2002 Feb;109(3):383-92
pubmed: 11827998
Invest Ophthalmol Vis Sci. 1998 Nov;39(12):2479-85
pubmed: 9804158
Cell Cycle. 2010 Sep 15;9(18):3700-9
pubmed: 20930545
J Cell Sci. 1999 Jun;112 ( Pt 12):1915-23
pubmed: 10341210
Genes Dev. 2002 May 1;16(9):1066-76
pubmed: 12000790
Pharmacol Ther. 2015 Apr;148:114-31
pubmed: 25435019
J Biol Chem. 1997 Mar 14;272(11):6986-93
pubmed: 9054388
Diabetes. 2005 Nov;54(11):3119-25
pubmed: 16249434
FEBS Lett. 1999 Apr 30;450(1-2):77-83
pubmed: 10350061
Biochem Biophys Res Commun. 2005 Apr 22;329(4):1225-33
pubmed: 15766557
J Cell Biol. 2002 Aug 19;158(4):773-85
pubmed: 12177047
Am J Pathol. 2006 Jul;169(1):314-24
pubmed: 16816383
FEBS Lett. 2003 Apr 10;540(1-3):7-14
pubmed: 12681475
EMBO Rep. 2002 Sep;3(9):834-9
pubmed: 12223464
Prog Retin Eye Res. 2013 May;34:19-48
pubmed: 23416119
J Ophthalmol. 2015;2015:138070
pubmed: 25802751
PLoS One. 2012;7(2):e32167
pubmed: 22348151
J Biol Chem. 2000 Jul 14;275(28):21435-43
pubmed: 10801826
Nat Rev Immunol. 2007 Oct;7(10):803-15
pubmed: 17893694
Arterioscler Thromb Vasc Biol. 2003 Jun 1;23(6):953-64
pubmed: 12689916
Cell. 2002 Mar 22;108(6):837-47
pubmed: 11955436
J Cell Sci. 2013 Jun 15;126(Pt 12):2545-9
pubmed: 23781019
EMBO J. 1998 Mar 2;17(5):1371-84
pubmed: 9482734
Am J Pathol. 2005 Jan;166(1):185-96
pubmed: 15632011
Mol Vis. 2003 May 01;9:171-8
pubmed: 12740568
Blood. 2011 Jun 2;117(22):6012-23
pubmed: 21464369
Invest Ophthalmol Vis Sci. 2014 Oct 21;55(11):7321-31
pubmed: 25335984
Pathophysiology. 2017 Dec;24(4):229-241
pubmed: 28732591
EMBO J. 2012 Jun 13;31(12):2714-36
pubmed: 22617422
Int J Mol Sci. 2018 Mar 22;19(4):
pubmed: 29565290
J Biol Chem. 2012 Jan 6;287(2):819-31
pubmed: 22110128
Cold Spring Harb Perspect Biol. 2009 Nov;1(5):a002949
pubmed: 20066120
Eur J Ophthalmol. 2011;21 Suppl 6:S3-9
pubmed: 23264323
Invest Ophthalmol Vis Sci. 2019 Feb 1;60(2):748-760
pubmed: 30793207
Semin Ophthalmol. 1999 Dec;14(4):240-8
pubmed: 10758225
Arterioscler Thromb Vasc Biol. 2007 Dec;27(12):2514-23
pubmed: 17872453
Acta Ophthalmol (Copenh). 1981 Oct;59(5):689-94
pubmed: 7315223
Proc Natl Acad Sci U S A. 2000 Oct 24;97(22):11960-5
pubmed: 11035810
Am J Physiol Heart Circ Physiol. 2005 Jan;288(1):H159-64
pubmed: 15319204